Acalabrutinib Monotherapy Shows Sustained Survival Benefit in Chronic Lymphocytic Leukemia Treatment
Acalabrutinib monotherapy offers sustained progression-free and overall survival in treatment-naive chronic lymphocytic leukemia.
A large EHR study finds reduced insulin use and lower rates of diabetes-related complications among patients undergoing ...
You may stop practicing, but can you stop being a doctor? Physicians say finding an identity in retirement can be a hard pill ...
Loncastuximab tesirine shows promise for patients with diffuse large B-cell lymphoma after multiple treatments, including relapse following chimeric antigen receptor T-cell therapy.
Many patients with nongranulomatous acute anterior uveitis may be diagnosed with previously unrecognized axial spondyloarthritis after rheumatologic evaluation.
A new sepsis score accurately identifies children with the highest risk for mortality after liver transplantation and infection.
A systematic review of patients with LUMBAR syndrome found that the anatomic midline was involved in all cases, raising the possibility that this is a diagnostic criterion.
Cardiac arrests during endoscopic procedures in the hospital are associated with lower mortality than those with other ...
Bipolar disorder is associated with a 72% increased risk for mortality over 8 years in older adults compared with the general ...
A novel adaptive test that quickly identifies autism with similar accuracy to conventional exams could soon be administered ...
Jazz Pharmaceuticals said it plans to ask the FDA to remove the second-line indication for lurbinectedin (Zepzelca) in metastatic small-cell lung cancer (SCLC). In its second-quarter 2026 financial ...
The incidence of invasive listeriosis has remained stable in the US from 2008 to 2023, although certain groups face ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results